Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Mesalamine
Dapagliflozin 10mg Tab
Locations
1
Egypt
Faculty of Medicine, Mansoura University
Al Mansurah, Egypt
Start Date
August 20, 2023
Primary Completion Date
August 20, 2027
Completion Date
July 20, 2028
Last Updated
March 13, 2026
NCT06226883
NCT06573723
NCT06579443
NCT07033208
NCT05733702
NCT06065228
Lead Sponsor
Mostafa Bahaa
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions